27.04.2012
- BASF had a solid start to 2012. Sales were higher than in the very good first quarter of the previous year and rose 6% to €20.6 billion. Income from operations (EBIT) before...
27.04.2012
- Eastman Chemical posted a decline in quarterly profit on Thursday but gave a better-than-expected outlook for the rest of the year, helped by capacity additions and its acquisition...
27.04.2012
- Hefty refining losses continued to weigh on profits at Chinese state oil giants PetroChina and Sinopec in the first three months of the year, with the latter posting a worse than...
27.04.2012
- Pharmaceutical firm Shire posted a 20% rise in first-quarter earnings on Thursday, just beating market expectations, as its drugs to treat hyperactivity again lifted market share...
27.04.2012
- U.S. drugmaker Bristol-Myers Squibb said on Thursday that it received a subpoena from securities regulators regarding its sales and marketing practices in various foreign countries...
26.04.2012
- AstraZeneca Chief Executive David Brennan is to step down on June 1 in an abrupt exit after six years in the top job, following rising investor discontent at the company's...
26.04.2012
- Air Liquide reported group revenue of €3,779 million for the first quarter 2012, up 6.7%. After a fourth quarter 2011 characterized by a slow-down in growth related to the global...
26.04.2012
- Johnson & Johnson is sending in a former Army Ranger to clean up several big messes that have hurt its reputation, earnings and share price in the past three years. Alex Gorsky...
26.04.2012
- The Federal Trade Commission on Wednesday lost its latest attempt to thwart deals to delay the production of cheaper, generic drugs that brand-name drug companies make with...
